Fluorouracil/Salicylic acid

氟尿嘧啶/水杨酸

Report date: 2022/07/04 19:38:02

Base Information

Drug NameFluorouracil/Salicylic acid
Drug Alias Name水杨酸/氟尿嘧啶Fluorouracil and Salicylic acidSalicylic acid/FluorouracilSalicylic acid and FluorouracilActikerall +[6
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsThymidylate synthase inhibitors
TargetsCyclooxygenasesThymidylate synthase
Therapy Area/IndicationsKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsKeratosis, Actinic

Other Information

ATC CodeN/A
Related LinksN/A